Men diagnosed at screening aged 50 years projected to have 16% chance that cancer would not have been detected within 15 years.

Veracyte, Inc. , a leading cancer diagnostics company, announced today that more than 15 studies focused on the Decipher portfolio will be presented at the 2026 American Urological Association (AUA) ...

What if you'd invested in Veracyte (VCYT) ten years ago? It may not have been easy to hold on to VCYT for all that time, but if you did, how much would your investment be worth today? With that in ...

SALT LAKE CITY, April 14, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan’s Ministry of ...

Proton beam therapy continues to generate significant interest — and controversy — in prostate cancer. About 45 cancer centers in the US offer proton therapy to treat a variety of cancers, including ...

A new study has found that metformin, a widely prescribed diabetes drug, may mimic one of exercise's core biological effects in men with prostate cancer, raising levels of a molecule tied to energy ...

This campaign wants you to lighten your load. FCancer, a nonprofit focused on cancer prevention and early detection, has declared its mission to “beat cancer off, literally” — imploring men to ...

New findings from VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM), published in Pharmacological Research, show that an innovative drug effectively prevents ...

VCYT rides on Afirma and Decipher growth with strong earnings beat and liquidity, but macro pressures and rising competition cloud its near-term outlook.

Women’s HRT patches can treat prostate cancer just as effectively as standard hormone injections – but with fewer of the worst side-effects – according to a large UK trial published in the New England ...

A major 23-year study on prostate cancer screening reveals that while more cases are detected, the actual reduction in death is surprisingly small. The findings challenge the popular belief that more ...

The idea is that most prostate cancers grow so slowly that they won't cause symptoms or shorten your lifespan, even if they’re left untreated. Prostate cancer treatments, on the other hand, can cause ...